THE USE OF MOLECULAR HYDROGEN IN CORRECTION OF NO-REFLOW SYNDROME IN THE POLYURIC STAGE OF SUBLIMATE NEPHROPATHY

Hydrogen Therapy: A New Hope for Kidney Health and No-Reflow Syndrome

A recent study explored the use of molecular hydrogen in treating No-Reflow Syndrome in rats with kidney disease. The results showed improved blood flow to the kidneys and reduced severity of the condition. This research has implications for human health and may offer a new way to improve kidney health.